Total Payments
$22,702
2022 Payments
$1,184
Companies
38
Transactions
291
Medicare Patients
4,312
Medicare Billing
$355,029
Payment Breakdown by Category
Other$12,150 (53.5%)
Consulting$5,250 (23.1%)
Food & Beverage$4,939 (21.8%)
Education$242.06 (1.1%)
Travel$120.99 (0.5%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program | $6,900 | 5 | 30.4% |
| Consulting Fee | $5,250 | 2 | 23.1% |
| Food and Beverage | $4,939 | 275 | 21.8% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $2,700 | 1 | 11.9% |
| Compensation for serving as faculty or as a speaker for a medical education program | $2,550 | 2 | 11.2% |
| Education | $242.06 | 4 | 1.1% |
| Travel and Lodging | $120.99 | 2 | 0.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Abbott Laboratories | $18,033 | 33 | $0 (2022) |
| Janssen Pharmaceuticals, Inc | $466.12 | 34 | $0 (2022) |
| Novartis Pharmaceuticals Corporation | $454.32 | 26 | $0 (2022) |
| Boston Scientific Corporation | $376.06 | 8 | $0 (2022) |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $288.17 | 15 | $0 (2022) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $265.80 | 15 | $0 (2022) |
| Bardy Diagnostics, Inc. | $245.00 | 9 | $0 (2022) |
| Amgen Inc. | $229.60 | 15 | $0 (2022) |
| AstraZeneca Pharmaceuticals LP | $223.73 | 10 | $0 (2022) |
| PFIZER INC. | $216.80 | 16 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2022 | $1,184 | 61 | Boston Scientific Corporation ($154.02) |
| 2021 | $3,645 | 55 | Abbott Laboratories ($2,804) |
| 2020 | $7,194 | 26 | Abbott Laboratories ($6,943) |
| 2019 | $825.25 | 46 | Bardy Diagnostics, Inc. ($125.00) |
| 2018 | $715.06 | 45 | SANOFI-AVENTIS U.S. LLC ($111.32) |
| 2017 | $9,139 | 58 | Abbott Laboratories ($8,071) |
All Payment Transactions
291 individual payment records from CMS Open Payments — Page 1 of 12
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/26/2022 | Abbott Laboratories | CARDIOMEMS (Device) | Food and Beverage | In-kind items and services | $12.41 | General |
| Category: Heart Failure | ||||||
| 08/10/2022 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $16.93 | General |
| Category: CARDIOVASCULAR | ||||||
| 08/09/2022 | Abbott Laboratories | AVEIR (Device) | Food and Beverage | In-kind items and services | $30.59 | General |
| Category: Cardiac Rhythm Management | ||||||
| 08/05/2022 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $14.81 | General |
| Category: Diabetes | ||||||
| 08/02/2022 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $16.66 | General |
| Category: Cardiology | ||||||
| 07/27/2022 | Merck Sharp & Dohme LLC | VERQUVO (Drug) | Food and Beverage | In-kind items and services | $13.98 | General |
| Category: CARDIOVASCULAR | ||||||
| 07/20/2022 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $17.42 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 07/19/2022 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $14.49 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 07/14/2022 | AtriCure, Inc. | EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX (Device) | Food and Beverage | In-kind items and services | $20.30 | General |
| Category: CARDIOVASCULAR | ||||||
| 07/13/2022 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $14.33 | General |
| Category: Cardiovascular | ||||||
| 07/07/2022 | AstraZeneca Pharmaceuticals LP | BRILINTA (Drug) | Food and Beverage | In-kind items and services | $16.63 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 07/06/2022 | Merck Sharp & Dohme LLC | VERQUVO (Drug) | Food and Beverage | In-kind items and services | $21.04 | General |
| Category: CARDIOVASCULAR | ||||||
| 06/29/2022 | Bardy Diagnostics, Inc. | Carnation Ambulatory Monitor (Device) | Food and Beverage | In-kind items and services | $15.00 | General |
| Category: Cardiac Arrhythmia Monitoring | ||||||
| 06/28/2022 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $24.22 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 06/17/2022 | Boston Scientific Corporation | Varithena Administration Pack (Device) | Food and Beverage | In-kind items and services | $18.77 | General |
| Category: Varithena_PI | ||||||
| 06/16/2022 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $23.05 | General |
| Category: DIABETES | ||||||
| 06/15/2022 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $18.04 | General |
| Category: CARDIOVASCULAR | ||||||
| 06/14/2022 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $15.32 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 06/09/2022 | AstraZeneca Pharmaceuticals LP | BRILINTA (Drug) | Food and Beverage | In-kind items and services | $11.98 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 06/08/2022 | Merck Sharp & Dohme LLC | VERQUVO (Drug) | Food and Beverage | In-kind items and services | $16.09 | General |
| Category: CARDIOVASCULAR | ||||||
| 06/07/2022 | Tactile Systems Technology Inc | Flexitouch Plus (Device), entre | Food and Beverage | In-kind items and services | $12.70 | General |
| Category: PNEUMATIC COMPRESSOR | ||||||
| 06/03/2022 | Edwards Lifesciences Corporation | Edwards SAPIEN 3 Ultra Transcatheter Heart Valve (Device) | Food and Beverage | In-kind items and services | $24.07 | General |
| Category: Transcatheter Heart Valves | ||||||
| 05/31/2022 | Merck Sharp & Dohme LLC | VERQUVO (Drug) | Food and Beverage | In-kind items and services | $16.87 | General |
| Category: CARDIOVASCULAR | ||||||
| 05/25/2022 | Alnylam Pharmaceuticals Inc. | ONPATTRO (Drug) | Food and Beverage | In-kind items and services | $13.82 | General |
| Category: Genetic Disease | ||||||
| 05/24/2022 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $19.44 | General |
| Category: CARDIOVASCULAR | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 141 | 141 | $65,040 | $14,321 |
| 2022 | 12 | 1,042 | 1,268 | $238,431 | $111,469 |
| 2021 | 13 | 1,604 | 2,061 | $307,221 | $123,317 |
| 2020 | 15 | 1,525 | 2,137 | $295,068 | $105,922 |
Total Patients
4,312
Total Services
5,607
Medicare Billing
$355,029
Procedure Codes
42
All Medicare Procedures & Services
42 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 129 | 129 | $64,500 | $14,210 | 22.0% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 12 | 12 | $540.00 | $111.10 | 20.6% |
| 93229 | Electrocardiogram (ecg) up to 30 days continuous with transmission of patient triggered events with review and report by health care professional | Office | 2022 | 65 | 66 | $62,700 | $44,905 | 71.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 293 | 353 | $57,892 | $30,365 | 52.5% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2022 | 125 | 125 | $62,500 | $16,749 | 26.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 60 | 60 | $14,040 | $6,641 | 47.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 94 | 94 | $10,622 | $5,485 | 51.6% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 246 | 263 | $11,835 | $2,585 | 21.8% |
| 93015 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | Office | 2022 | 37 | 37 | $10,582 | $1,874 | 17.7% |
| 93228 | Electrocardiogram (ecg) up to 30 days continuous with review and report by health care professional | Office | 2022 | 67 | 68 | $3,740 | $1,211 | 32.4% |
| 93793 | Anticoagulant management of patient taking warfarin | Office | 2022 | 15 | 85 | $1,318 | $606.09 | 46.0% |
| 93294 | Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | Office | 2022 | 16 | 28 | $1,400 | $564.96 | 40.4% |
| 85610 | Blood test, clotting time | Office | 2022 | 13 | 76 | $1,178 | $322.83 | 27.4% |
| 93296 | Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | Office | 2022 | 11 | 13 | $624.00 | $162.18 | 26.0% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 398 | 632 | $103,648 | $56,822 | 54.8% |
| 93306 | Ultrasound examination of heart including color-depicted blood flow rate, direction, and valve function | Office | 2021 | 240 | 243 | $121,500 | $35,864 | 29.5% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 102 | 102 | $23,868 | $12,553 | 52.6% |
| 93000 | Routine ekg using at least 12 leads including interpretation and report | Office | 2021 | 357 | 375 | $16,875 | $4,008 | 23.8% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 56 | 58 | $6,554 | $3,544 | 54.1% |
| 93244 | Heart rhythm review, and interpretation of continous external ekg over more than 48 hours up to 7 days | Office | 2021 | 167 | 168 | $8,400 | $3,234 | 38.5% |
| 93015 | Exercise or drug-induced heart and blood vessel stress test with ekg monitoring, physician supervision, interpretation, and report | Office | 2021 | 48 | 48 | $13,728 | $2,474 | 18.0% |
| 93242 | Heart rhythm recording continous external ekg over more than 48 hours up to 7 days | Office | 2021 | 167 | 168 | $5,880 | $1,933 | 32.9% |
| 93793 | Anti-clotting management for patient taking warfarin | Office | 2021 | 12 | 96 | $1,488 | $754.32 | 50.7% |
| 93280 | Evaluation, testing, and programming adjustment of permanent dual lead pacemaker system with physician analysis, review, and report | Office | 2021 | 16 | 23 | $1,380 | $699.66 | 50.7% |
| 93294 | Remote evaluations of single, dual, or multiple lead pacemaker system with qualified health care professional analysis, review, and report, up to 90 days | Office | 2021 | 13 | 23 | $1,150 | $529.76 | 46.1% |
About Dr. Daniel Einhorn, D.O
Dr. Daniel Einhorn, D.O is a Cardiovascular Disease healthcare provider based in Chandler, Arizona. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/20/2006. The National Provider Identifier (NPI) number assigned to this provider is 1215996186.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Daniel Einhorn, D.O has received a total of $22,702 in payments from pharmaceutical and medical device companies, with $1,184 received in 2022. These payments were reported across 291 transactions from 38 companies. The most common payment nature is "Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program" ($6,900).
As a Medicare-enrolled provider, Einhorn has provided services to 4,312 Medicare beneficiaries, totaling 5,607 services with total Medicare billing of $355,029. Data is available for 4 years (2020–2023), covering 42 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Location Chandler, AZ
- Active Since 03/20/2006
- Last Updated 09/08/2011
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1215996186
Products in Payments
- FreeStyle Libre Pro (Device) $17,513
- XARELTO (Drug) $466.12
- ENTRESTO (Drug) $454.32
- LifeVest (Device) $288.17
- CardioMEMS HF System (Device) $267.30
- ELIQUIS (Drug) $260.84
- Carnation Ambulatory Monitor (Device) $245.00
- Repatha (Biological) $208.19
- Ozempic (Drug) $175.13
- PRALUENT (Drug) $157.18
- WATCHMAN DEVICE (Device) $140.09
- PRADAXA (Drug) $135.83
- WATCHMAN Access System (Device) $135.25
- VERQUVO (Drug) $134.65
- Vascepa (Drug) $134.56
- JARDIANCE (Drug) $129.97
- PRALUENT (Biological) $102.80
- BRILINTA (Drug) $90.57
- PRALUENT ALIROCUMAB INJECTION (Biological) $89.68
- NEXLETOL (Drug) $87.32
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Chandler
Dr. Pratik Dalal
Cardiovascular Disease — Payments: $162,416
Cardiovascular Disease $162,416
Dr. Ashish Pershad, Md, MD
Cardiovascular Disease — Payments: $159,542
Cardiovascular Disease $159,542
Dr. Marc Silver, M.d, M.D
Cardiovascular Disease — Payments: $93,495
Cardiovascular Disease $93,495
Georges Nseir, Md, MD
Cardiovascular Disease — Payments: $85,125
Cardiovascular Disease $85,125
Huy Phan, M.d., Ph.d, M.D., PH.D
Cardiovascular Disease — Payments: $35,341
Cardiovascular Disease $35,341
Dr. Gautam Kedia, M.d, M.D
Cardiovascular Disease — Payments: $21,365
Cardiovascular Disease $21,365